The stock price for Precision Biosciences Inc (DTIL) currently stands at $0.44. The stock experienced a substantial increase in the last session, hitting $0.4366 after starting at $0.3882. The stock’s lowest price was $0.3882 before closing at $0.38.
In terms of market performance, Precision Biosciences Inc had a fairly uneven. The highest value for the stock in the past year was $1.60 on 11/18/22, and the lowest value was recorded at $0.28 on 10/27/23.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
52-week price history of DTIL Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Precision Biosciences Inc’s current trading price is -72.71% away from its 52-week high, while its distance from the 52-week low is 58.76%. The stock’s price range during this period has spanned from $0.28 to $1.60. In the Healthcare sector, the Precision Biosciences Inc’s shares surpassed a trading volume of approximately 1.56 million for the day, which was noticeably higher compared to the average daily volume of 9.1.02 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Precision Biosciences Inc (DTIL) has experienced a quarterly decline of -2.98% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 51.93M and boasts a workforce of 198 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4513, with a change in price of -0.0892. Similarly, Precision Biosciences Inc recorded 1,054,733 in trading volume during the last 100 days, posting a change of -16.96%.
Examining DTIL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for DTIL stands at 0.82. Similarly, the long-term debt-to-equity ratio is also 0.00.
DTIL Stock Stochastic Average
Today, Precision Biosciences Inc’s raw stochastic average for the past 50 days stands at 87.26%, indicating a decline from the raw stochastic average of the last 20 days, which was 98.00%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 74.35% and 59.56% respectively.
DTIL Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -63.31%. However, over the past six months, we’ve seen a stronger performance of -43.80%. The price of DTIL fallen by 44.09% over the last 30 days. And in the last five days, it has surged by 15.26%.
